What Does Rachel Sherman Think About Top FDA Regulatory Issues?

Greenwood adn Sherman
BIO CEO James Greenwood and FDA's Rachel Sherman at BIO CEO & Investor Conference • Source: Photo by Brenda Sandburg

More from US FDA

More from Agency Leadership